Investigation of the serum level of pregnancy-associated alpha2-globulin during contraceptive treatment by means of radial immunodiffusion method.
The serum level of pregnancy-associated alpha2-globulin was studied in 70 healthy women taking three different types of oral contraceptives [40 Bisecurin: containing 1.0 mg of Ethynodiol diaceticum +0.05 mg Ethynilestradiol; 20 Infecundin: containing 2.5 mg of Norethynodrel +0.1 mg of Mestranol; 10 Cervicundin: containing of 0.5 mg Ethynodiol diaceticum]. Elevated amounts of serum level of pregnancy associated alpha2-globulin could be detected in 37 of the 40 women taking Bisecurin and in all 20 taking Infecundin. Cervicundin however, failed to induce any change in the serum protein pattern of the 10 subjects studied. Serum levels of pregnancy-associated alpha2-globulin were higher in the Infecundin-taking (53 mg %), than in the Bisecurin-taking group (29 mg %). This shows the oestrogen dependency of the pregnancy-associated alpha2-globulin and points to a possible implication of this globulin in the immunosuppressive processes.
D000510:Alpha-Globulins / Q000032:analysis*; D003276:Contraceptives, Oral / Q000494:pharmacology*; D003280:Contraceptives, Oral, Synthetic / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005040:Ethynodiol Diacetate / Q000494:pharmacology*; D005260:Female; D006801:Humans; D005779:Immunodiffusion; D008656:Mestranol / Q000494:pharmacology*; D009641:Norethynodrel / Q000494:pharmacology*; D011247:Pregnancy; D013268:Stimulation, Chemical
D000510:Alpha-Globulins; D003276:Contraceptives, Oral; D003280:Contraceptives, Oral, Synthetic; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D008656:Mestranol